Cargando…

Expression of Bcl-2 is a favorable prognostic biomarker in lung squamous cell carcinoma

Lung squamous cell carcinoma (LUSC) is the second major type of lung cancer globally. The majority of patients with LUSC are clinically diagnosed at the advanced stages, thus it is urgent to identify suitable prognostic markers for LUSC. B-cell lymphoma 2 (Bcl-2) has been widely studied in non-small...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Changjiang, Wu, Jiaqi, Yang, Fan, Qiu, Mangtang, Hu, Shuofeng, Guo, Saisai, Wu, Jin, Ying, Xiaomin, Wang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920356/ https://www.ncbi.nlm.nih.gov/pubmed/29725421 http://dx.doi.org/10.3892/ol.2018.8198

Ejemplares similares

Schlafen 12 Is Prognostically Favorable and Reduces C-Myc and Proliferation in Lung Adenocarcinoma but Not in Lung Squamous Cell Carcinoma
por: Al-Marsoummi, Sarmad, et al.
Publicado: (2020)

Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma
por: Li, Zongcheng, et al.
Publicado: (2016)

High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology
por: Anagnostou, Valsamo K, et al.
Publicado: (2010)

Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma
por: Theelen, W. S. M. E., et al.
Publicado: (2020)

Overexpression of E-Cadherin Is a Favorable Prognostic Biomarker in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Lorenzo-Pouso, Alejandro I., et al.
Publicado: (2023)

Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma
por: Gao, Xujie, et al.
Publicado: (2016)

IL6 and BCL3 Expression Are Potential Biomarkers in Esophageal Squamous Cell Carcinoma
por: Soares-Lima, Sheila Coelho, et al.
Publicado: (2021)

The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies
por: Ho, Hsiang-Ling, et al.
Publicado: (2019)

Identification and in vitro validation of diagnostic and prognostic biomarkers for lung squamous cell carcinoma
por: Zhao, Xiaopeng, et al.
Publicado: (2022)

A Tumor-Specific Prognostic Long Non-Coding RNA Signature in Gastric Cancer
por: Ren, Wu, et al.
Publicado: (2016)

A six-mRNA prognostic model to predict survival in head and neck squamous cell carcinoma
por: Tian, Saisai, et al.
Publicado: (2018)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma
por: Liu, Huanqing, et al.
Publicado: (2022)

Identification of Potential Prognostic Biomarkers Associated with Monocyte Infiltration in Lung Squamous Cell Carcinoma
por: Liu, Hailin, et al.
Publicado: (2022)

Novel cellular senescence-related risk model identified as the prognostic biomarkers for lung squamous cell carcinoma
por: Hu, Xiaoshan, et al.
Publicado: (2022)

Tumor-Infiltrating CD4(+) Central Memory T Cells Correlated with Favorable Prognosis in Oral Squamous Cell Carcinoma
por: Wu, Jin, et al.
Publicado: (2022)

Investigation on the potential of circulating tumor DNA methylation patterns as prognostic biomarkers for lung squamous cell carcinoma
por: Liu, Yutao, et al.
Publicado: (2020)

Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival
por: Xing, Shan, et al.
Publicado: (2017)

microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2
por: Ma, Xianpeng, et al.
Publicado: (2020)

Immune-active tumor-adjacent tissues are associated with favorable prognosis in stage I lung squamous cell carcinoma
por: Ying, Lisha, et al.
Publicado: (2023)

Molecular stratification by BCL2A1 and AIM2 provides additional prognostic value in penile squamous cell carcinoma
por: Tan, Xingliang, et al.
Publicado: (2021)

HPV Positive Status Is a Favorable Prognostic Factor in Non-Nasopharyngeal Head and Neck Squamous Cell Carcinoma Patients: A Retrospective Study From the Surveillance, Epidemiology, and End Results Database
por: Wu, Qiuji, et al.
Publicado: (2021)

Development and validation of an individualized immune prognostic model in stage I–III lung squamous cell carcinoma
por: Yang, Qi-Fan, et al.
Publicado: (2021)

Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma
por: Huang, Guang-zhao, et al.
Publicado: (2019)

RGN as a prognostic biomarker with immune infiltration and ceRNA in lung squamous cell carcinoma
por: Liao, Yang, et al.
Publicado: (2023)

Prognostic Value of Selected Histologic Features for Lung Squamous Cell Carcinoma
por: Fan, Justine, et al.
Publicado: (2022)

Weighted gene expression profiles identify diagnostic and prognostic genes for lung adenocarcinoma and squamous cell carcinoma
por: Wu, Xing, et al.
Publicado: (2019)

PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma
por: Gong, Siming, et al.
Publicado: (2023)

BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous carcinoma
por: Lazarus, Kyren A., et al.
Publicado: (2018)

PD-L1 expression on immune cells is a favorable prognostic factor for vulvar squamous cell carcinoma patients
por: Sznurkowski, Jacek J., et al.
Publicado: (2017)

LIMK2 Is a Novel Prognostic Biomarker and Correlates With Tumor Immune Cell Infiltration in Lung Squamous Cell Carcinoma
por: Su, Yongcheng, et al.
Publicado: (2022)

Midkine as a prognostic biomarker in oral squamous cell carcinoma
por: Ota, K, et al.
Publicado: (2008)

FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma
por: Wu, Qingqing, et al.
Publicado: (2022)

Ideal prognostic model in lung squamous cell carcinoma
por: Kinoshita, Tomonari
Publicado: (2020)

Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma
por: Hyeon, Jiyeon, et al.
Publicado: (2013)

The Diagnostic and Prognostic Roles of Combined Expression of Novel Biomarkers in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: An Immunohistochemical Study
por: Alabiad, Mohamed Ali, et al.
Publicado: (2021)

Biomarkers Suggesting Favorable Prognostic Outcomes in Sudden Sensorineural Hearing Loss
por: Doo, Jeon Gang, et al.
Publicado: (2020)

Human sperm-associated antigen 4 as a potential prognostic biomarker of lung squamous cell carcinoma
por: Wang, Yongheng, et al.
Publicado: (2021)

Minichromosome maintenance gene family: potential therapeutic targets and prognostic biomarkers for lung squamous cell carcinoma
por: Yang, Xuejie, et al.
Publicado: (2022)

GABRP is a Promising Prognostic Biomarker and Associated with Immune Cell Infiltration in Lung Squamous Cell Carcinoma
por: Fu, Jiding, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b3pq4i450d2enedoleocq5jc6u